potus yield & quality enhancer
crop culture pty ltd - trinexapac-ethyl - emulsifiable concentrate - trinexapac-ethyl cyclohexanediones active 250.0 g/l - herbicide - poppy | ryegrass seed crop | sugar cane | inter-row spraying | ratoon sugar cane | sugarcane - increase commercial cane sugar (ccs) | increase seed yield | modify alkaloid ratio | commercial cane sugar percenta | improved seed set | improving the percentage of th
tweak yield & quality enhancer
fmc australasia pty ltd - trinexapac-ethyl - emulsifiable concentrate - trinexapac-ethyl cyclohexanediones active 250.0 g/l - herbicide - poppy - modify alkaloid ratio | improving the percentage of th
moddus yield & quality enhancer
syngenta australia pty ltd - trinexapac-ethyl - emulsifiable concentrate - trinexapac-ethyl cyclohexanediones active 250.0 g/l - herbicide - poppy | ryegrass seed crop | sugar cane | inter-row spraying | ratoon sugar cane | sugarcane - increase commercial cane sugar (ccs) | increase seed yield | modify alkaloid ratio | commercial cane sugar percenta | improved seed set | improving the percentage of th
fentanyl viatris
viatris limited - fentanyl 10.2mg (alkaloid powder) - transdermal patch - 100 mcg/h - active: fentanyl 10.2mg (alkaloid powder) excipient: dimeticone polyolefin film (mediflex 1000) 25 square centimeters polyester release liner (scotchpak 1022) 37.34 square centimeters no-tox white fgn-4194 nt23 silicone adhesive - mylan fentanyl patch is indicated in the management of chronic cancer pain. mylan fentanyl patch is also indicated in the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. it is indicated for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.
fentanyl viatris
viatris limited - fentanyl 1.28mg (alkaloid powder) - transdermal patch - 12 mcg/h - active: fentanyl 1.28mg (alkaloid powder) excipient: dimeticone polyolefin film (mediflex 1000) 3.13 square centimeters polyester release liner (scotchpak 1022) 10.16 square centimetres no-tox white fgn-4194 nt23 silicone adhesive - mylan fentanyl patch is indicated in the management of chronic cancer pain. mylan fentanyl patch is also indicated in the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. it is indicated for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.
fentanyl viatris
viatris limited - fentanyl 2.55mg (alkaloid powder) - transdermal patch - 25 mcg/h - active: fentanyl 2.55mg (alkaloid powder) excipient: dimeticone polyolefin film (mediflex 1000) 6.25 square centimeters polyester release liner (scotchpak 1022) 13.21 square centimetres no-tox white fgn-4194 nt23 silicone adhesive - mylan fentanyl patch is indicated in the management of chronic cancer pain. mylan fentanyl patch is also indicated in the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. it is indicated for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.
fentanyl viatris
viatris limited - fentanyl 5.1mg (alkaloid powder) - transdermal patch - 50 mcg/h - active: fentanyl 5.1mg (alkaloid powder) excipient: dimeticone polyolefin film (mediflex 1000) 12.5 square centimeters polyester release liner (scotchpak 1022) 22.35 square centimeters no-tox white fgn-4194 nt23 silicone adhesive - mylan fentanyl patch is indicated in the management of chronic cancer pain. mylan fentanyl patch is also indicated in the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. it is indicated for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.
fentanyl viatris
viatris limited - fentanyl 7.65mg (alkaloid powder) - transdermal patch - 75 mcg/h - active: fentanyl 7.65mg (alkaloid powder) excipient: dimeticone polyolefin film (mediflex 1000) 18.75 square centimeters polyester release liner (scotchpak 1022) 28.45 square centimeters no-tox white fgn-4194 nt23 silicone adhesive - mylan fentanyl patch is indicated in the management of chronic cancer pain. mylan fentanyl patch is also indicated in the management of opioid-responsive chronic severe pain of non-malignant origin in opioid tolerant patients, after other conservative methods of analgesia have been tried. it is indicated for use in accordance with nzma guidelines on chronic pain management and where there is no psychological contraindication, drug seeking behaviour or history of drug misuse.
belladonna 0.25% w/w medicated plaster
cuxson gerrard & company ltd - belladonna alkaloids - medicated plaster - 0.25 percent weight/weight - other topical products for joint and muscular pain; various
hepax liq liquid
sabex inc - cynara scolymus; combretum; uva ursi; boldo; hawthorn; adonis vernalis; magnesium chloride; boldo alkaloid; peptone - liquid - 5g; 3.6g; 2.4g; 2g; 1g; 230mg; 1g; 65g; 2g - cynara scolymus 5g; combretum 3.6g; uva ursi 2.4g; boldo 2g; hawthorn 1g; adonis vernalis 230mg; magnesium chloride 1g; boldo alkaloid 65g; peptone 2g - herbs and natural products